Predicting the risk of secondary lung malignancies associated with whole-breast radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 4, 2012, Pages 1101-1106

  Ng, John ^a   Shuryak, Igor ^a   Xu, Yanguang ^a   Clifford Chao, K S ^a   Brenner, David J ^a   Burri, Ryan J ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

Early stage breast cancer; Hypofractionation; Prone breast irradiation; Secondary malignancy; Whole breast irradiation

Indexed keywords

BREAST IRRADIATION; EARLY-STAGE BREAST CANCER; HYPOFRACTIONATION; SECONDARY MALIGNANCY; WHOLE-BREAST IRRADIATION;

BIOLOGICAL ORGANS; COMPUTERIZED TOMOGRAPHY; DISEASES; IRRADIATION; PATIENT TREATMENT;

RADIATION;

ADULT; AGED; ARTICLE; BODY POSTURE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOGRAM; HUMAN; INTRADUCTAL CARCINOMA; LUNG METASTASIS; PATIENT POSITIONING; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INDUCED NEOPLASM; RISK ASSESSMENT; SECONDARY LUNG MALIGNANCY; SUPINE POSITION; TREATMENT PLANNING; WHOLE BREAST RADIATION THERAPY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG NEOPLASMS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PATIENT POSITIONING; PRONE POSITION; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SUPINE POSITION;

EID: 84862785756     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.09.052     Document Type: Article

References (46)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Jemal A, Ward E, Thun M. Declining death rates reflect progress against cancer. PLoS One 2010;5:e9584.
3. Luini A, Gatti G, Zurrida S, et al. The evolution of the conservative approach to breast cancer. Breast 2007;16:120-129.
4. Recht A, Solin LJ. Breast-conserving surgery and radiotherapy in early-stage breast cancer: The importance of local control. Semin Radiat Oncol 2011;21:3-9.
5. Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007;168:1-64.
6. Metayer C, Lynch CF, Clarke EA, et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 2000;18:2435-2443.
7. Travis LB, Hill D, Dores GM, et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst 2005;97:1428-1437.
8. Lorigan P, Radford J, Howell A, et al. Lung cancer after treatment for Hodgkin's lymphoma: A systematic review. Lancet Oncol 2005;6:773-779.
9. Stegman LD, Beal KP, Hunt MA, et al. Long-term clinical outcomes of whole-breast irradiation delivered in the prone position. Int J Radiat Oncol Biol Phys 2007;68:73-81.
10. Formenti SC, Gidea-Addeo D, Goldberg JD, et al. Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol 2007;25:2236-2242.
11. Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010;362:513-520.
12. Shuryak I, Hahnfeldt P, Hlatky L, et al. A new view of radiationinduced cancer: Integrating short- and long-term processes. Part I: Approach. Radiat Environ Biophys 2009;48:263-274.
13. Shuryak I, Hahnfeldt P, Hlatky L, et al. A new view of radiation-induced cancer: Integrating short- and long-term processes. Part II: Second cancer risk estimation. Radiat Environ Biophys 2009;48:275-286.
14. Shuryak I, Sachs RK, Brenner DJ. A new view of radiation-induced cancer. Radiat Prot Dosimetry 2011;143:358-364.
15. Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. http://seer.cancer.gov/
16. Deutsch M, Land SR, Begovic M, et al. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. Cancer 2003;98:1362-1368.
17. Woodward WA, Strom EA, McNeese MD, et al. Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. Int J Radiat Oncol Biol Phys 2003;57:327-335.
18. Olivotto IA, Truong PT, Chua B. Postmastectomy radiation therapy: Who needs it? J Clin Oncol 2004;22:4237-4239.
19. Fernando SA, Edge SB. Evidence and controversies in the use of postmastectomy radiation. J Natl Compr Canc Netw 2007;5:331-338.
20. Zablotska LB, Neugut AI. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer 2003;97:1404-1411.
21. Kirova YM, Gambotti L, De Rycke Y, et al. Risk of second malignancies after adjuvant radiotherapy for breast cancer: A large-scale, single-institution review. Int J Radiat Oncol Biol Phys 2007;68:359-363.
22. Inskip PD, Stovall M, Flannery JT. Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst 1994;86:983-988.
23. Neugut AI, Murray T, Santos J, et al. Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers. Cancer 1994;73:1615-1620.
24. Travis LB, Curtis RE, Inskip PD, et al. Re: Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst 1995;87:60-61.
25. Prochazka M, Granath F, Ekbom A, et al. Lung cancer risks in women with previous breast cancer. Eur J Cancer 2002;38:1520-1525.
26. Neugut AI, Robinson E, Lee WC, et al. Lung cancer after radiation therapy for breast cancer. Cancer 1993;71:3054-3057.
27. Galper S, Gelman R, Recht A, et al. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2002;52:406-414.
28. Roychoudhuri R, Evans H, Robinson D, et al. Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer 2004;91:868-872.
29. Prochazka M, Hall P, Gagliardi G, et al. Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: Case-only design. J Clin Oncol 2005;23:7467-7474.
30. Wiernik PH, Sklarin NT, Dutcher JP, et al. Adjuvant radiotherapy for breast cancer as a risk factor for the development of lung cancer. Med Oncol 1994;11:121-125.
31. NIH consensus conference. Treatment of early-stage breast cancer. JAMA 1991;265:391-395.
32. Griem KL, Fetherston P, Kuznetsova M, et al. Three-dimensional photon dosimetry:Acomparison of treatment of the intact breast in the supine and prone position. Int J Radiat Oncol Biol Phys 2003;57:891-899.
33. Alonso-Basanta M, Ko J, Babcock M, et al. Coverage of axillary lymph nodes in supine vs. prone breast radiotherapy. Int J Radiat Oncol Biol Phys 2009;73:745-751.
34. Merchant TE, McCormick B. Prone position breast irradiation. Int J Radiat Oncol Biol Phys 1994;30:197-203.
35. DeWyngaert JK, Jozsef G, Mitchell J, et al. Accelerated intensity-modulated radiotherapy to breast in prone position: Dosimetric results. Int J Radiat Oncol Biol Phys 2007;68:1251-1259.
36. Goodman KA, Hong L, Wagman R, et al. Dosimetric analysis of a simplified intensity modulation technique for prone breast radiotherapy. Int J Radiat Oncol Biol Phys 2004;60:95-102.
37. Formenti SC, Truong MT, Goldberg JD, et al. Prone accelerated partial breast irradiation after breast-conserving surgery: Preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 2004;60:493-504.
38. Zhao X, Wong EK, Wang Y, et al. A support vector machine (SVM) for predicting preferred treatment position in radiotherapy of patients with breast cancer. Med Phys 2010;37:5341-5350.
39. Varga Z, Hideghety K, Mezo T, et al. Individual positioning: A comparative study of adjuvant breast radiotherapy in the prone versus supine position. Int J Radiat Oncol Biol Phys 2009;75:94-100.
40. Darby SC, McGale P, Taylor CW, et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005;6:557-565.
41. Kaufman EL, Jacobson JS, Hershman DL, et al. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol 2008;26:392-398.
42. Ford MB, Sigurdson AJ, Petrulis ES, et al. Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer 2003;98:1457-1464.
43. Obedian E, Fischer DB, Haffty BG. Second malignancies after treatment of early-stage breast cancer: Lumpectomy and radiation therapy versus mastectomy. J Clin Oncol 2000;18:2406-2412.
44. Vikström J, Hjelstuen MH, Mjaaland I, et al. Cardiac and pulmonary dose reduction for tangentially irradiated breast cancer, utilizing deep inspiration breath-hold with audio-visual guidance, without compromising target coverage. Acta Oncol 2011;50:42-50.
45. Kirby AM, Evans PM, Helyer SJ, et al. A randomised trial of Supine versus Prone breast radiotherapy (SuPr study): Comparing set-up errors and respiratory motion. Radiother Oncol 2011;100(2):221-226.
46. National Surgical Adjuvant Breast and Bowel Project (NSABP). Protocol B-39/RTOG 0413. A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer. Available at: http://www.nsabp.pitt.edu/B-39.asp. Accessed October 25, 2011.